NEW

Health Care Leaders Form Trustworthy & Responsible AI Network (TRAIN)

Monday, at the HIMSS 2024 Global Health Conference, a new consortium of healthcare leaders announced the creation of the Trustworthy & Responsible AI Network (TRAIN), which aims to operationalize responsible AI principles to improve the quality, safety and...

EPA Rule to Slash EtO Emissions, Reduce Cancer Risk

The U.S. Environmental Protection Agency has announced a rule that will reduce lifetime cancer risks for people living near commercial sterilization facilities across the country. The final amendments to the air toxics standards for ethylene oxide commercial...

AI Revolutionizes General Surgery, says GlobalData

Artificial intelligence (AI) integration in general surgery has surged, promising revolutionary advancements in precision and patient outcomes. AI tools have transformed preoperative planning, intraoperative assistance, and postoperative care, enhancing diagnostic...

Study Shows Potential for Using AI Tools to Detect Healthcare-Associated Infections

A new proof-of-concept study published today in the American Journal of Infection Control (AJIC) reports that artificial intelligence (AI) technologies can accurately identify cases of healthcare-associated infections (HAI) even in complex clinical scenarios. The...

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization. The hardware agnostic imaging module has been designed to provide surgeons real-time intraoperative visual data and imaging not currently available to surgeons through existing technologies, helping to improve patient outcomes and safety in the operating room.

“Receiving FDA 510(k) clearance for our ActivSight enhanced visualization module is a significant milestone in bringing Activ Surgical’s technology to operating rooms around the world,” said Todd Usen, CEO of Activ Surgical. “Given there is a $36 billion cost for preventable surgical errors, we believe ActivSight has the potential to make an immediate impact in the OR. We look forward to working closely with our initial pilot customers over the next several months to further validate ActivSight and revolutionize surgical care.”

ActivSight is the company’s proprietary hardware imaging module that will power its next product, ActivInsights. ActivInsights will be part of the ActivEdge software platform, which will use artificial intelligence (AI) and machine learning (ML) technology to produce surgical insights. The first ActivInsight that will be made available is perfusion insights and will offer the ability to see blood flow and perfusion in real time, without the use of traditional dyes.

For more information, visit https://www.activsurgical.com/#about.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X